Beigene Ltd
ONC326.060USD
-2.650-0.81%
收盤 09/26, 16:00（美東）報價延遲15分鐘
32.94B總市值
虧損本益比TTM
關於 公司
公司簡介
公司代碼ONC
公司名稱Beigene Ltd
上市日期- -
CEOMr. John Victor Oyler
員工數量11000
證券類型Ordinary Share
年結日- -
公司地址c/o BeOne Medicines I GmbH
城市BASEL
上市交易所The Toronto Stock Exchange
國家Switzerland
郵編4051
電話41616851900
網址
公司代碼ONC
上市日期- -
CEOMr. John Victor Oyler
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Xiaobin Wu, Ph.D.
Mr. Xiaobin Wu, Ph.D.
President, Chief Operating Officer, General Manager, China
President, Chief Operating Officer, General Manager, China
10.89K
--
Mr. Lai Wang
Mr. Lai Wang
Global Head of R&D
Global Head of R&D
--
--
MR. Aaron Rosenberg
MR. Aaron Rosenberg
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Olivier Brandicourt, M.D.
Dr. Olivier Brandicourt, M.D.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Giancarlo Benelli
Mr. Giancarlo Benelli
Senior Vice President, Head of Europe
Senior Vice President, Head of Europe
--
--
Mr. Chan Lee, J.D.
Mr. Chan Lee, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
--
--
Ms. Shalini Sharp
Ms. Shalini Sharp
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Xiaodong Wang, Ph.D.
Dr. Xiaodong Wang, Ph.D.
Co-Founder, Non-Executive Director
Co-Founder, Non-Executive Director
--
--
Dr. Han (Margaret) Dugan, M.D.
Dr. Han (Margaret) Dugan, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. John Victor Oyler
Mr. John Victor Oyler
Co-Founder, Executive Chairman of the Board, Chief Executive Officer
Co-Founder, Executive Chairman of the Board, Chief Executive Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Xiaobin Wu, Ph.D.
Mr. Xiaobin Wu, Ph.D.
President, Chief Operating Officer, General Manager, China
President, Chief Operating Officer, General Manager, China
10.89K
--
Mr. Lai Wang
Mr. Lai Wang
Global Head of R&D
Global Head of R&D
--
--
MR. Aaron Rosenberg
MR. Aaron Rosenberg
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Olivier Brandicourt, M.D.
Dr. Olivier Brandicourt, M.D.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Giancarlo Benelli
Mr. Giancarlo Benelli
Senior Vice President, Head of Europe
Senior Vice President, Head of Europe
--
--
Mr. Chan Lee, J.D.
Mr. Chan Lee, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
--
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Product
1.09B
97.61%
BRUKINSA
791.66M
70.86%
Tislelizumab
171.16M
15.32%
XGEVA
70.42M
6.30%
BLINCYTO
23.91M
2.14%
其他
-1.03B
-92.23%
地區USD
名稱
營收
佔比
United States
567.21M
50.77%
China
399.59M
35.76%
Europe
118.55M
10.61%
ROW
31.92M
2.86%
業務
地區
業務USD
名稱
營收
佔比
Product
1.09B
97.61%
BRUKINSA
791.66M
70.86%
Tislelizumab
171.16M
15.32%
XGEVA
70.42M
6.30%
BLINCYTO
23.91M
2.14%
其他
-1.03B
-92.23%
股東統計
更新時間: 18 小時前
更新時間: 18 小時前
持股股東
股東類型
持股股東
持股股東
佔比
Amgen Inc
17.27%
Baker Bros. Advisors LP
8.02%
PRIMECAP Management Company
4.64%
Capital International Investors
4.45%
Fidelity Management & Research Company LLC
3.11%
其他
62.50%
持股股東
持股股東
佔比
Amgen Inc
17.27%
Baker Bros. Advisors LP
8.02%
PRIMECAP Management Company
4.64%
Capital International Investors
4.45%
Fidelity Management & Research Company LLC
3.11%
其他
62.50%
股東類型
持股股東
佔比
Investment Advisor
18.07%
Corporation
17.28%
Hedge Fund
9.62%
Investment Advisor/Hedge Fund
4.28%
Sovereign Wealth Fund
1.13%
Research Firm
0.63%
Bank and Trust
0.07%
Pension Fund
0.05%
Family Office
0.02%
其他
48.85%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
558
63.29M
57.54%
+456.15K
2025Q1
585
69.06M
63.84%
+3.36M
2024Q4
575
70.01M
71.38%
+1.65M
2024Q3
603
67.03M
68.90%
-2.04M
2024Q2
601
66.99M
69.35%
-2.19M
2024Q1
621
66.56M
67.86%
-955.35K
2023Q4
626
65.12M
66.49%
-3.71M
2023Q3
632
67.27M
67.88%
-2.05M
2023Q2
655
66.79M
67.58%
-3.13M
2023Q1
655
67.68M
71.16%
-4.10M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Amgen Inc
18.94M
17.28%
--
--
Feb 20, 2025
Baker Bros. Advisors LP
8.80M
8.03%
--
--
Mar 31, 2025
PRIMECAP Management Company
5.06M
4.61%
-43.40K
-0.85%
Mar 31, 2025
Capital International Investors
5.09M
4.64%
-1.02M
-16.72%
Mar 31, 2025
Fidelity Management & Research Company LLC
3.36M
3.07%
+1.58M
+88.38%
Mar 31, 2025
HHLR Advisors, Ltd.
1.03M
0.94%
--
--
May 09, 2025
Temasek Holdings Pte. Ltd.
993.75K
0.91%
-531.58K
-34.85%
Mar 31, 2025
T. Rowe Price International Ltd
1.30M
1.19%
-143.22K
-9.92%
Mar 31, 2025
Citadel Advisors LLC
982.16K
0.9%
+665.05K
+209.72%
Mar 31, 2025
Invus Public Equities Advisors, LLC
498.69K
0.46%
-155.03K
-23.72%
Mar 31, 2025
查看更多
持股ETF
更新時間: 9月6日 週六
更新時間: 9月6日 週六
機構名稱
佔比
Goldman Sachs MarketBeta Emerging Markets Eqty ETF
0%
Goldman Sachs Innovate Equity ETF
0%
Goldman Sachs MarketBeta Total Internatl Eqty ETF
0%
T Rowe Price Small-Mid Cap ETF
0%
T Rowe Price US Equity Research ETF
0%
Invesco ESG NASDAQ Next Gen 100 ETF
0%
Invesco NASDAQ Next Gen 100 ETF
0%
Goldman Sachs MarketBeta Emerging Markets Eqty ETF
佔比0%
Goldman Sachs Innovate Equity ETF
佔比0%
Goldman Sachs MarketBeta Total Internatl Eqty ETF
佔比0%
T Rowe Price Small-Mid Cap ETF
佔比0%
T Rowe Price US Equity Research ETF
佔比0%
Invesco ESG NASDAQ Next Gen 100 ETF
佔比0%
Invesco NASDAQ Next Gen 100 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
